Astrix Technology LLC

Astrix Technology LLC, doing business as Astrix Technology Group, is a for-profit limited liability company based in Red Bank, New Jersey, that supplies specialized scientific, research, technical, and administrative personnel to federal biomedical research agencies as a prime contractor (100% of recent awards) on an unrestricted, full-and-open competitive basis with no SBA set-aside certifications. The vendor operates exclusively through the GSA Multiple Award Schedule, competing without subcontractor footprint and delivering directly across the National Institutes of Health enterprise using internally staffed personnel across labor categories ranging from junior biologists at $56.13 per hour through senior subject matter experts at $286.48 per hour.

Astrix's customer concentration sits overwhelmingly within NIH. The top five funding entities account for 81% of recent awards by count, dominated by the National Heart, Lung and Blood Institute (399 awards, $62.3 million combined potential value), the National Cancer Institute (382 awards, $155.2 million combined potential value), and the NIH Office of Logistics and Acquisition Operations as aggregation point (191 awards, $80.1 million combined potential value). By dollar value, the top five entities represent 30% of combined potential value, with NCI leading at $155.2 million. The National Eye Institute, the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Deafness and Other Communication Disorders, and a dozen other NIH components round out the remainder. Astrix holds no significant commercial or defense footprint; the award portfolio is almost entirely NIH institutes and one USDA contract (LabVantage LIMS Phase V implementation, $1.75 million, January 2024).

Astrix's vehicle position concentrates on two parent vehicles: a $20 million single-award Blanket Purchase Agreement with the NIH Office of Logistics and Acquisition Operations awarded May 7, 2024, with performance through May 31, 2025, covering scientific support, office support, and temporary help services, and a $19.41 million single-award BPA with the National Institute on Deafness and Other Communication Disorders awarded September 26, 2022, with performance through September 25, 2027, also covering scientific support, office support, and temporary help services. Both vehicles sit under the GSA Multiple Award Schedule parent. These two IDVs anchor the delivery model: recent task orders against these vehicles include a $628,344 call for scientific support services to NIDCD (September 2026), a $1.23 million call for two project manager positions to NIAID (April 2026), a $573,770.40 call for senior scientific staff to NIDCD (November 2024), and dozens of smaller individual placements in the $10,000–$400,000 range per order. The vendor places the vast majority of work (1,371 of 1,372 awards, or 100%) as prime; only one sub-award appears in the source (Leidos RIC support services, September 2025).

Capability portfolio reflects pure staffing and specialized personnel placement across biomedical research and clinical support disciplines. Concrete named work includes clinical research nurses and nurse practitioners (NIAAA, ongoing), biostatisticians and statistical programmers (multiple institutes), laboratory technicians and biologists (NIDCD, NHLBI, NCI), project managers and program specialists (across NIH), regulatory and clinical trials managers (NHLBI), MRI/CT/echo technologists (NHLBI cardiac labs), scientific data specialists (NCI, NHGRI), and grant management specialists. Unlike systems integrators or software vendors, Astrix does not deliver tools, platforms, or managed services; it deploys named personnel in time-and-materials or labor-hour-priced task orders, typically priced firm fixed. Recent examples: two junior scientific researchers (cell engineering) for $332,046 (March 2026); one part-time research pathologist for $175,069 (February 2026); a biospecimen technician/scientific researcher for $46,952 (May 2025); and audiology assistant staffing for $319,334 through August 2027 (September 2024). Work is performed at NIH campuses in Bethesda, Maryland, the NIH Clinical Center in Bethesda, and Astrix's Red Bank, New Jersey headquarters.

Recent activity has declined sharply: 191 awards in 2022, 135 in 2023, 100 in 2024, 47 in 2025, and 34 year-to-date in 2026. SCI-reported invoicing reflects the same trajectory: $12.6 million in FY2022 across 81.1 FTEs, declining to $7.7 million in FY2024 across 40.9 FTEs. Government-paid median hourly rates on SCI records run around $72.92/hr; the 10th percentile sits at $48.29/hr and the 90th percentile at $139.81/hr. Combined potential value across the full 1,372-award footprint reaches $1.06 billion, with $310.7 million obligated (29% of potential). Sixty-four awards face ultimate completion in the next twenty-four months (combined potential value $28.8 million), presenting recompete exposure; however, these are distributed across many small individual task orders rather than concentrated on a small number of large vehicles. The vendor's primary parent vehicles—the $20 million NIH Office of Logistics and Acquisition Operations BPA (expiring May 2025) and the $19.41 million NIDCD BPA (expiring September 2027)—represent the strategic infrastructure; loss or recompete of either would substantially disrupt the delivery model.

Astrix competes exclusively on an unrestricted basis across GSA MAS against mainstream commercial labor-staffing vendors without differentiation through set-asides, security clearances, technical certifications, or intellectual property. The vendor operates no meaningful subcontractor network and carries no apparent teaming relationships in the award record. This posture positions Astrix as a flexible, low-friction staffing solution for NIH institutes seeking to fill specialized personnel slots without hiring full-time civil service staff, but also leaves the vendor vulnerable to NIH budget constraints, hiring freezes, and competition from larger staffing providers. The sharp decline in annual award count over four years (from 191 to 34 year-to-date in 2026) suggests either a contraction in NIH temporary staffing demand or loss of market share to competitors on the same GSA vehicle.